www.neuroendocrinecancer.org.uk
If you have a phaeochromocytoma or paraganglioma, precautions may also need to be considered to avoid a hormone-related crisis. Please discuss this with your specialist and treatment team. As with Carcinoid Crisis, UKINETs guidance can help with planning care.
Hair Thinning
RLT may cause temporary hair thinning. You may have already experienced this if you have been on a somatostatin analogue (Lanreotide or Octreotide). Hair thinning usually lessens, and lost hair can be replaced by new growth once RLT treatment is completed.
Fatigue
Fatigue can be challenging to deal with—especially if you are already experiencing fatigue due to your neuroendocrine tumour (NET). However, some people have reported improvements between treatments and after RLT has concluded. Not only can treatment-related fatigue reduce, but pre-treatment fatigue may also improve once RLT has finished, although this may take some time to be fully appreciated.
Made with FlippingBook Annual report maker